Cargando…
Development of Immunoassays for the Quantitative Assessment of Amyloid-β in the Presence of Therapeutic Antibody: Application to Pre-Clinical Studies
Utilizing decision making biomarkers in drug development requires thorough assay validation. Special considerations need to be taken into account when monitoring biomarkers using immunoassays in the presence of therapeutic antibodies. We have developed robust and sensitive assays to assess target en...
Autores principales: | Bogstedt, Anna, Groves, Maria, Tan, Keith, Narwal, Rajesh, McFarlane, Mary, Höglund, Kina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878309/ https://www.ncbi.nlm.nih.gov/pubmed/26402635 http://dx.doi.org/10.3233/JAD-142988 |
Ejemplares similares
-
Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017) -
Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
por: Trysberg, Estelle, et al.
Publicado: (2004) -
Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β
por: Henderson, Simon J., et al.
Publicado: (2014) -
PRESENCE OF BACTERIA IN DENTINAL TUBULES
por: Kina, José Ricardo, et al.
Publicado: (2008) -
Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
por: Chapuy-Regaud, Sabine, et al.
Publicado: (2021)